| Paul Hastings | Chief Executive Officer | FY2025 | |
| Nadir Mahmood, Ph.D. | President | FY2025 | |
| Shawn Rose, M.D., Ph.D. | Chief Medical Officer and Head of Research and Development | FY2025 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.